Rapid human immunodeficiency virus test quality assurance practices and outcomes among testing sites affiliated with 17 public health departments.
Rapid human immunodeficiency virus testing is often conducted in nonclinical settings by staff with limited training, so quality assurance (QA) monitoring is critical to ensure accuracy of test results. Rapid tests (n = 86,749) were generally conducted according to manufacturers' instructions, but ongoing testing competency assessments and on-site QA monitoring were not uniformly conducted.
Wesolowski
Laura G
LG
Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. lig7@cdc.gov
Ethridge
Steven F
SF
Martin
Eugene G
EG
Cadoff
Evan M
EM
MacKellar
Duncan A
DA
D006678:HIV / Q000302:isolation & purification*; D015658:HIV Infections / Q000175:diagnosis*; D006302:Health Services Research; D006801:Humans; D013677:Medical Laboratory Science / Q000379:methods* / Q000592:standards*; D011634:Public Health; D011785:Quality Assurance, Health Care / Q000379:methods*; D014773:Virology / Q000379:methods*
AIDS. 2006 Aug 1;20(12):1661-6
16868448
Curr Infect Dis Rep. 2006 Mar;8(2):125-31
16524549
AIDS. 2006 Aug 1;20(12):1655-60
16868447
J Clin Microbiol. 2008 May;46(5):1692-7
18353938
PLoS One. 2007 Jan 31;2(1):e185
17268576
J Clin Virol. 2004 Jul;30(3):229-32
15135740